Rankings
▼
Calendar
GERN
Geron Corporation
$1B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$460,000
-56.8% YoY
Gross Profit
-$51M
-11046.1% margin
Operating Income
-$73M
-15762.0% margin
Net Income
-$69M
-14901.7% margin
EPS (Diluted)
$-0.33
Cash Flow
Operating Cash Flow
-$44M
Free Cash Flow
-$44M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$166M
Total Liabilities
$30M
Stockholders' Equity
$135M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$460,000
$1M
-56.8%
Gross Profit
-$51M
-$12M
-335.9%
Operating Income
-$73M
-$31M
-133.3%
Net Income
-$69M
-$27M
-153.7%
← Q4 2018
All Quarters
Q1 2019 →
GERN FY 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena